NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed its oligonucleotide microarray patents to Invitrogen, OGT said today.
 
With the license, Invitrogen can offer DNA related microarray services to customers worldwide from its US operations.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.